Traditional PivotTables have always intimidated me. I see there is a new Excel function called PIVOTBY. What is the ...

Corcept's ALS drug dazucorilant improved survival despite missing the main goal; ovarian cancer drug combo met its target in ...

Receiving ganciclovir prophylaxis did not have a benefit on respiratory support-free days vs. placebo in adults with ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

Despite high specificity, the tests show low sensitivity for early-stage cancers, necessitating further validation through ...

In patients with lung cancer, more patients managed with current vs. more intensive surveillance guidelines for small ...

Less inflammatory diets were linked to improved overall survival in stage III colon cancer, and physical activity showed ...

At Google I/O, Google revealed the next-gen search engine that analyzes, summarizes, and acts. Available worldwide starting ...

Thursday's testimony in the Karen Read trial concluded. Catch a recap of the day here as the prosecution rested its case.

Welcher received a report on May 8 from Shanon Burgess, his colleague, who found “new information that changed the timing,” he said. Burgess’s report concerned a “clock variance” between Read’s SUV ...

Deaths among COVID-19 patients have surged in the last three weeks. A total of 40 Covid patients died since mid-May, which is ...

The FDA approved Nubeqa for metastatic castration-sensitive prostate cancer based on significantly improved radiographic ...